Study: Tdap vaccine as safe and effective as Td vaccine in seniors

11/30/2012 | MedPage Today (free registration)

The tetanus-diphtheria-acellular pertussis vaccine was comparable in safety and efficacy with tetanus and diphtheria vaccine in patients ages 65 and older, according to a study published online in the journal Clinical Infectious Diseases. Tdap vaccine users showed no increased risk of adverse reactions including meningitis and encephalitis compared with Td users. Seniors who received the Tdap vaccine, however, were nearly four times more likely to develop generalized reaction and anaphylaxis and were more likely to need medical attention for allergic or inflammatory reactions within six days of vaccination.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR